Vitamin K Toxicity: What the Evidence Shows

Here is the honest bottom line, stated up front: the natural forms of vitamin K — K1 (phylloquinone) from leafy greens and K2 (the menaquinones) from fermented foods and animal products — have no established toxicity in humans, even at intakes far above what anyone eats. The expert panels that set nutrient limits in both the United States and Europe looked for a level high enough to cause harm and could not find one, so they declined to set an upper limit for vitamin K at all. The body simply does not store excess vitamin K to dangerous levels; it uses what it needs, recycles a great deal of it, and clears the rest. There is one genuine historical exception — an old synthetic form called K3 (menadione), which was abandoned for human use decades ago because it could damage red blood cells — and one real, frequently-misunderstood interaction: for people taking the blood thinner warfarin, what matters is keeping vitamin K intake steady, because swings in intake shift how the drug works. That is a drug-management issue, not vitamin K "toxicity." This page lays out what the evidence actually says, why the biology makes harm so unlikely, who the rare edge cases are, and the practical takeaways. It is correct that this page is short and reassuring: a vitamin K toxicity syndrome is not a recognized clinical problem.

Table of Contents

  1. What the Evidence Actually Says
  2. Why Vitamin K Is So Hard to Overdose On
  3. The Real Exception: Synthetic K3 (Menadione)
  4. The Warfarin Question: Consistency, Not Toxicity
  5. Who, If Anyone, Should Be Careful
  6. What to Do in Practice
  7. When to Seek Care / Red Flags
  8. Key Research Papers
  9. Connections
  10. Featured Videos

What the Evidence Actually Says

When you hear the word "toxicity" attached to a vitamin, it is fair to assume there is some dose at which it becomes harmful. For the fat-soluble vitamins this is often true — too much vitamin A or vitamin D can genuinely cause illness. Vitamin K is the striking exception. Natural vitamin K — both the plant form K1 (phylloquinone) and the K2 menaquinones — has no documented toxicity in humans at any intake studied, whether from food or from ordinary supplements. This is not a gap in the research; it is a positive finding repeated by the bodies whose entire job is to find a vitamin's danger threshold.

The most authoritative example is the U.S. Institute of Medicine (IOM, now the National Academy of Medicine). When it set the Dietary Reference Intakes for vitamin K in 2001, it established an Adequate Intake (the amount needed for health — about 120 micrograms a day for adult men and 90 for adult women) but explicitly did not set a Tolerable Upper Intake Level (UL). The reason it gave is telling: there were no credible reports of harm from high intakes of the natural forms on which to base a limit. In plain terms, the experts went looking for a ceiling and concluded there was no evidence one was needed.

Europe reached the same conclusion independently. In 2017 the European Food Safety Authority (EFSA) reviewed vitamin K to set its own dietary reference values and likewise found no basis to establish an upper limit, noting the absence of adverse effects from observed intakes. Two of the world's most rigorous nutrition panels, working separately, arrived at the same place: vitamin K from food and standard supplements is not a toxicity concern.

It is worth being precise about what this does and does not mean. It does not mean vitamin K is "magic" or that you should take limitless doses — "no established upper limit" is a statement about safety data, not an invitation to megadose, and more of a nutrient is not automatically better. And it does not erase the two real caveats covered below: the obsolete synthetic form K3, and the warfarin interaction. But for the ordinary question — can I get too much vitamin K from kale, from natto, from a K1 or K2 supplement? — the evidence-based answer is no.

Back to Table of Contents

Why Vitamin K Is So Hard to Overdose On

The safety of vitamin K is not luck; it falls out of how the body handles it. Several features of its biology make accumulation to a harmful level essentially impossible from natural sources.

Put together, these traits explain the clinical observation: even large oral doses of K1 or K2, including the milligram-range doses used in some bone and cardiovascular studies, have a strong safety record without a recognized poisoning syndrome. The deeper biology of how vitamin K activates these proteins is covered on the Vitamin K and Blood Clotting page and the Vitamin K Benefits hub.

Back to Table of Contents

The Real Exception: Synthetic K3 (Menadione)

There is exactly one form of vitamin K with a documented capacity to cause harm, and it is important to name it clearly because it is the source of most "vitamin K can be toxic" claims. That form is menadione, the synthetic compound once called vitamin K3. Menadione is not a natural dietary vitamin; it is a manufactured, water-soluble precursor that the body can convert into active vitamin K. Decades ago it was given to humans, including newborns, before its problems became clear.

The trouble with menadione is chemical. Unlike the natural K1 and K2 molecules, menadione can behave as a pro-oxidant: it can react with cell components and generate reactive oxygen species, and at high doses it stresses red blood cells in particular. In susceptible infants — and especially in people with an inherited red-cell enzyme deficiency called G6PD deficiency — this could trigger hemolysis (the breakdown of red blood cells), leading to anemia and a buildup of bilirubin (jaundice). In newborns, high bilirubin carries its own danger to the developing brain.

Because of this, menadione was withdrawn from use as a human vitamin K supplement — for example, the U.S. Food and Drug Administration moved away from it for human nutritional use many years ago — and was replaced by the natural form. Infants today are given K1 (phylloquinone), which does not have menadione's pro-oxidant problem, to prevent the bleeding disorder of the newborn (see the Vitamin K Deficiency hub). Menadione still appears in some animal feeds, but that is a separate context and not how people get their vitamin K.

The honest framing matters here. The historical harm from menadione is real, but it does not transfer to the vitamin K in your diet or in a modern K1/K2 supplement. Conflating the two is the single most common error in this topic. When someone says "vitamin K can be toxic," the accurate response is: the obsolete synthetic K3 could be, which is exactly why it is no longer used in people; the natural forms you actually consume are not.

Back to Table of Contents

The Warfarin Question: Consistency, Not Toxicity

The other thing people have heard — "I'm told to watch my vitamin K" — is real, but it is routinely misfiled under "toxicity." It is not. It is a drug interaction, and the goal is the opposite of what many assume.

Warfarin (brand name Coumadin) is a blood thinner that works precisely by blocking the vitamin K cycle — it inhibits the enzyme that regenerates vitamin K, which lowers the activity of the vitamin K–dependent clotting factors and so reduces clotting. The drug's effect is therefore exquisitely sensitive to how much vitamin K is around. When dietary vitamin K goes up, it partly counteracts the drug, and the blood becomes more prone to clotting (the INR, a blood test of clotting time, falls). When dietary vitamin K drops, the drug's effect strengthens and bleeding risk rises (the INR climbs). A landmark systematic review of warfarin's food and drug interactions confirms vitamin K–rich foods as a clinically meaningful, well-documented modifier of the drug's effect.

Here is the crucial, counter-intuitive point: the advice to people on warfarin is not to avoid vitamin K — it is to keep their intake consistent from week to week. A steady, predictable amount of leafy greens lets the warfarin dose be calibrated to it. The danger is not vitamin K itself but variability: a sudden green-juice cleanse, or suddenly cutting out all vegetables, can swing the INR and is far riskier than a stable diet that happens to include kale every day. Many clinicians today explicitly encourage warfarin patients to eat their usual vegetables and simply not lurch between extremes.

Two clarifications keep this honest. First, this interaction is specific to vitamin K antagonists like warfarin; it does not apply to the newer direct oral anticoagulants (such as apixaban, rivaroxaban, or dabigatran), which do not work through the vitamin K cycle and have no vitamin K food restriction. Second — and this is the whole point of this section — none of this is "vitamin K toxicity." Vitamin K is not harming the person; it is interacting with a medication designed to oppose it. If you take warfarin, do not change your vitamin K intake — or start a vitamin K supplement — without talking to the clinician who manages your INR.

Back to Table of Contents

Who, If Anyone, Should Be Careful

For the general public, vitamin K from food and standard supplements requires no special caution at all. The short list of people for whom it is worth a thought is genuinely short, and in most cases the issue is an interaction or a specific medical context — not a risk of poisoning.

What is not on this list is just as important: there is no recognized risk of vitamin K toxicity from eating large amounts of leafy greens, fermented foods, or natto, and no condition in which a person's blood becomes dangerously over-clotted from dietary vitamin K alone.

Back to Table of Contents

What to Do in Practice

Because there is no toxicity syndrome to prevent, the practical guidance is refreshingly low-key — the real actions are about getting enough vitamin K and managing the warfarin interaction if it applies to you.

For the deficiency side of vitamin K — which, unlike toxicity, can matter clinically (newborns, malabsorption, certain medications) — see the Vitamin K Deficiency hub.

Back to Table of Contents

When to Seek Care / Red Flags

Because natural vitamin K has no toxicity syndrome, there are no "vitamin K overdose" symptoms to watch for. The situations that genuinely warrant medical attention all relate to the warfarin interaction or to unrelated bleeding/clotting problems — not to the vitamin building up. Contact your clinician (or seek urgent care for the severe items) if:

For the broader topic of clotting and bleeding, see Vitamin K and Blood Clotting and the Coagulation Panel lab-test page.

Back to Table of Contents

Key Research Papers

  1. Institute of Medicine, Food and Nutrition Board (2001). Vitamin K. In: Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. Washington, DC: National Academies Press. (Adequate Intake set; no Tolerable Upper Intake Level established.) — DOI: 10.17226/10026
  2. EFSA Panel on Dietetic Products, Nutrition and Allergies (Turck D, Bresson J-L, et al.) (2017). Dietary reference values for vitamin K. EFSA Journal;15(5):e04780. (No upper limit could be established.) — DOI: 10.2903/j.efsa.2017.4780
  3. Booth SL (2009). Roles for Vitamin K Beyond Coagulation. Annual Review of Nutrition;29:89-110. — DOI: 10.1146/annurev-nutr-080508-141217
  4. DiNicolantonio JJ, Bhutani J, O'Keefe JH (2015). The health benefits of vitamin K. Open Heart;2(1):e000300. — DOI: 10.1136/openhrt-2015-000300
  5. Villa JKD, Diaz MAN, Pizziolo VR, Martino HSD (2016). Effect of vitamin K in bone metabolism and vascular calcification: A review of mechanisms of action and evidences. Critical Reviews in Food Science and Nutrition;57(18):3959-3970. — DOI: 10.1080/10408398.2016.1211616
  6. Geleijnse JM, Vermeer C, Grobbee DE, et al. (2004). Dietary Intake of Menaquinone Is Associated with a Reduced Risk of Coronary Heart Disease: The Rotterdam Study. The Journal of Nutrition;134(11):3100-3105. — DOI: 10.1093/jn/134.11.3100
  7. Ferland G (2012). Vitamin K and the Nervous System: An Overview of its Actions. Advances in Nutrition;3(2):204-212. — DOI: 10.3945/an.111.001784
  8. Holbrook AM, Pereira JA, Labiris R, et al. (2005). Systematic Overview of Warfarin and Its Drug and Food Interactions. Archives of Internal Medicine;165(10):1095-1106. — DOI: 10.1001/archinte.165.10.1095
  9. Marles RJ, Roe AL, Oketch-Rabah HA (2017). US Pharmacopeial Convention safety evaluation of menadione (vitamin K3). Nutrition Reviews. — PubMed

PubMed Topic Searches

Back to Table of Contents

Connections

Back to Table of Contents